Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

l-Carnitine Improves Skeletal Muscle Fat Oxidation in Primary Carnitine Deficiency

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. A Polygenic Risk Score Suggests Shared Genetic Architecture of Voice Break With Early Markers of Pubertal Onset in Boys

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The Effect of Overweight and Obesity on Liver Biochemical Markers in Children and Adolescents

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effect of the incretin hormones on the endocrine pancreas in end-stage renal disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Gene Expression in Granulosa Cells From Small Antral Follicles From Women With or Without Polycystic Ovaries

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Hydroxylated Long-Chain Acylcarnitines are Biomarkers of Mitochondrial Myopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Absence of p.R50X Pygm read-through in McArdle disease cellular models

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Danish expanded newborn screening is a successful preventive public health programme

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Hydroxylated Long-Chain Acylcarnitines are Biomarkers of Mitochondrial Myopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Exercise therapy for muscle and lower motor neuron diseases

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Context: Primary carnitine deficiency (PCD) is an inborn error of fatty acid metabolism. Patients with PCD are risk for sudden heart failure upon fasting or illness if they are not treated with daily l-carnitine.

Objective: To investigate energy metabolism during exercise in patients with PCD with and without l-carnitine treatment.

Design: Interventional study.

Setting: Hospital exercise laboratories and department of cardiology.

Participants: Eight adults with PCD who were homozygous for the c.95A>G (p.N32S) mutation and 10 healthy age- and sex-matched controls.

Intervention: Four-day pause in l-carnitine treatment.

Main outcome measures: Total fatty acid and palmitate oxidation rates during 1-hour submaximal cycle ergometer exercise assessed with stable isotope method (U13C-palmitate and 2H2-d-glucose) and indirect calorimetry with and without l-carnitine.

Results: Total fatty acid oxidation rate was higher in patients with l-carnitine treatment during exercise than without treatment [12.3 (SD, 3.7) vs 8.5 (SD, 4.6) µmol × kg-1 × min-1; P = 0.008]. However, the fatty acid oxidation rate was still lower in patients treated with l-carnitine than in the healthy controls [29.5 (SD, 10.1) µmol × kg-1 × min-1; P < 0.001] and in the l-carnitine group without treatment it was less than one third of that in the healthy controls (P < 0.001). In line with this, the palmitate oxidation rates during exercise were lower in the no-treatment period [144 (SD, 66) µmol × kg-1 × min-1] than during treatment [204 (SD, 84) µmol × kg-1 × min-1; P = 0.004) .

Conclusions: The results indicate that patients with PCD have limited fat oxidation during exercise. l-Carnitine treatment in asymptomatic patients with PCD may not only prevent cardiac complications but also boost skeletal muscle fat metabolism during exercise.

Original languageEnglish
JournalThe Journal of clinical endocrinology and metabolism
Volume103
Issue number12
Pages (from-to)4580-4588
Number of pages9
ISSN0021-972X
DOIs
Publication statusPublished - 1 Dec 2018

ID: 55677641